YC S23
Nanograb
Deliver genes to any cell with AI
About
Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.
Founders
- Debesh Mandal
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Nanograb.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryNanomedicineBiotechDrug DeliveryTherapeutics